norcantharidin has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Du, LJ; Feng, YX; He, ZX; Huang, L; Wang, Q; Wen, CP; Zhang, Y | 1 |
| Chen, X; Fang, X; Li, Y; Shan, Y; Tang, C; Tao, Y; Tian, J; Wei, J; Xiao, Z; Zeng, D | 1 |
| Ding, X; Li, D; Wang, D; Wang, Z; Xu, W; Yang, C; Yang, Y; Zheng, Q | 1 |
| An, FY; Chen, XJ; Geng, GQ; Li, ZD; Liu, XS; Liu, YQ; Luo, LL; Sun, SB; Xie, XR; Zhang, XP | 1 |
| Liu, ZM; Sha, QM; Wan, XF; Wang, GC; Wang, JQ; Yang, GZ; Zhang, YL; Zheng, D | 1 |
| Colvin, D; Ehtesham, M; Khan, IS; McLaughlin, B; Odom, M; Quarles, CC; Singer, RJ | 1 |
| Chen, CQ; Fan, YZ; Fu, JY; Sun, W; Zhao, ZM | 1 |
9 other study(ies) available for norcantharidin and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Norcantharidin ameliorates the development of murine lupus via inhibiting the generation of IL-17 producing cells.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Female; Interleukin-17; Lupus Erythematosus, Systemic; Mice; Mice, Inbred MRL lpr; Th17 Cells | 2022 |
NCTD Prevents Renal Interstitial Fibrosis via Targeting Sp1/lncRNA Gm26669 Axis.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Drug Delivery Systems; Epithelial Cells; Fibrosis; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Kidney; Kidney Tubules, Proximal; Lentivirus; Male; Mice; Mice, Inbred C57BL; Nephritis, Interstitial; Real-Time Polymerase Chain Reaction; RNA, Long Noncoding; Sp1 Transcription Factor; Transfection; Transforming Growth Factor beta1 | 2021 |
Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomarkers; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coix; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Humans; Immunophenotyping; Liver Neoplasms; Mice; Plant Oils; Seeds; T-Lymphocytes, Regulatory; Xenograft Model Antitumor Assays | 2017 |
Norcantharidin combined with diamminedichloroplatinum inhibits tumor growth and cancerometastasis of hepatic carcinoma in murine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease Models, Animal; Drug Synergism; Female; Humans; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Treatment Outcome | 2018 |
[Effect of Norcantharidin on Hematopoietic Function in Leucopenia Model Rat Induced by Cyclophosphamide].
Topics: Animals; Apoptosis; Bone Marrow; Bone Marrow Cells; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Proliferation; Cyclophosphamide; Disease Models, Animal; Flow Cytometry; Hematologic Diseases; Hematopoiesis; Rats; Rats, Sprague-Dawley | 2015 |
Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities.
Topics: Animals; Brain Ischemia; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Injections, Intra-Arterial; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Rats; Stroke | 2016 |
Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatin; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gallbladder Neoplasms; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Time Factors; Xenograft Model Antitumor Assays | 2010 |